Mahmoud Khaled M, Ammar Amany S
Department of Anesthesiology, Faculty of Medicine, Minoufiya University, Shebin El-Kom, Minoufiya, Egypt.
Saudi J Anaesth. 2011 Apr;5(2):132-7. doi: 10.4103/1658-354X.82779.
The infraclavicular brachial plexus block (ICB) is designed to deposit anesthetic high in the plexus, achieving anesthesia of the hand, forearm, elbow, and distal arm. Adenosine is a metabolic intermediate that is involved in nearly all aspects of cell function, including neurotransmission and signal transduction.This study was aimed to show whether addition of adenosine to bupivacaine in ultrasound-guided ICB had an analgesic effect.
Sixty adult patients were divided into two equal groups, each group included 30 patients. Group I received infraclavicular bupivacaine 0.325% in a volume of 30 ml. Group II received 30 ml of 0.325% bupivacaine + 12 mg adenosine. The block was maintained with an infusion of 10 ml/h. The following parameters were assessed: Success rate, time of the sensory onset, motor block, visual analog scale (VAS), and amount of i.v. pethidine needed.
This study showed an analgesic effect of infraclavicular adenosine as evidenced by a statistically significant shorter mean time of onset of the sensory block (16 vs. 20 min, P < 0.05), lower mean VAS score over 48 h (1.7 vs. 2.7, P < 0.05), longer mean time of first parenteral analgesic requirement (299 vs. 255 min, P < 0.05), and lower mean total dose of pethidine needed over 48 h after surgery (25.5 vs. 56.6 mg, P <0.05). All patients got successful infraclavicular block and recovered uneventfully without any sensory or motor deficit.
Adenosine may provide valuable addition to the therapeutic options in anesthesia and pain management. Further research is required to figure out its exact role.
锁骨下臂丛神经阻滞(ICB)旨在将麻醉剂注射到神经丛较高位置,以实现对手部、前臂、肘部和上臂远端的麻醉。腺苷是一种代谢中间产物,几乎参与细胞功能的各个方面,包括神经传递和信号转导。本研究旨在表明在超声引导下的ICB中,在布比卡因中添加腺苷是否具有镇痛作用。
60例成年患者被分为两组,每组30例。第一组接受30ml 0.325%的锁骨下布比卡因。第二组接受30ml 0.325%布比卡因+12mg腺苷。通过10ml/h的输注维持阻滞。评估以下参数:成功率、感觉起效时间、运动阻滞、视觉模拟评分(VAS)以及所需静脉注射哌替啶的量。
本研究显示锁骨下腺苷具有镇痛作用,表现为感觉阻滞的平均起效时间在统计学上显著缩短(16分钟对20分钟,P<0.05),48小时内的平均VAS评分更低(分别为1.7和2.7,P<0.05),首次需要非肠道镇痛的平均时间更长(299分钟对255分钟,P<0.05),以及术后48小时内所需哌替啶的平均总剂量更低(25.5mg对56.6mg,P<0.05)。所有患者锁骨下阻滞均成功,恢复顺利,无任何感觉或运动功能缺损。
腺苷可能为麻醉和疼痛管理的治疗选择提供有价值的补充。需要进一步研究以明确其确切作用。